Multiple Sclerosis Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been diagnosed with multiple sclerosis (MS) based on a specific set of medical guidelines called the 2024 McDonald criteria.
- People whose level of physical disability from MS falls within a certain range, as measured by a standard medical scale called the EDSS (a score of 2 up to, but not including, 6).
- People who are between 18 and 65 years of age.
- People who score above 24 on a standard memory and thinking test called the Mini-Mental State Examination (MMSE).
- People who are willing to take part in the study.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have had an MS relapse (a flare-up of symptoms) within the last three months.
- People who have a long-term heart or lung condition that may affect breathing muscle strength, such as COPD, asthma, interstitial lung disease, or heart failure.
- People who currently have a lung infection.
- People who have bone or joint problems (confirm with trial site).
- People who have a psychiatric (mental health) condition.
- People who are pregnant.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Maximal inspiratory pressure (MIP); Maximal expiratory pressure (MEP); Forced Vital Capacity (FVC); Forced Expiratory Volume (FEV1); Tiffeneau Index (FEV1/FVC); Peak Expiratory Flow (PEF); Cough strength
Can't join this trial?
Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.